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Abstract
Bacterial spores are robust and dormant life forms with formidable resistance properties, in part,
attributable to the multiple layers of protein that encase the spore in a protective and flexible
shield. The coat has a number of features pertinent to the emerging field of nanobiotechnology
including self-assembling protomers and the capacity for engineering and delivery of foreign
molecules. This review gives an account of recent progress describing the use of the spore, and
specifically, the spore coat as a vehicle for heterologous antigen presentation and protective
immunization (vaccination). As interest in the spore coat increases it seems likely that they will be
exploited further for drug and enzyme delivery as well as a source of novel self-assembling proteins.
Background
Nanostructured surfaces exhibit unique physical and
chemical properties that can be exploited for many impor-
tant technological applications to produce molecular
structures and systems for the assembly within the nano-
metre size range. Nanotechnology not only can produce
surfaces with novel functionality, but also new devices
that are cheaper and faster than conventional ones, and
which may have other advantages. There are numerous
biological applications of nanotechnology, including self-
assembly of supramolecular structures, slow release and
delivery of enzymes and drugs, biocoatings and molecular
switches actuated by chemicals, electrons or light. Many of
these applications involve the development of sophisti-
cated self-assembled surface substrates, particularly those
with defined spacing. The emerging science of nanobio-
technology relies on the observation that, through evolu-
tion, nature has produced highly complex nanostructures
using macromolecules, especially nucleic acids, polysac-
charides and proteins. Accordingly, by understanding the
principles of how these macromolecules interact to pro-
duce nanostructures, it should be possible to exploit this
knowledge in the design and synthesis of new artificial
structures and devices. The advantages of this "learning
from nature" approach is that well defined fabrication
processes already exist in bacteria.
Many organisms, particularly microorganisms, have novel
and interesting structures that could be exploited, for
example, the lattice-type crystalline arrays of bacterial S-
layers [1,2] and bacterial spore coats [3] both of which
have protective properties. This review will examine recent
studies exploiting the bacterial spore as a vaccine vehicle
where the spore coat has been used for the display of het-
erologous antigens. In principle, the spore coat could be
used not only as a delivery vehicle for a variety of different
molecules but also as a source of new and novel self-
assembling proteins.
Surface Display Systems
Biological applications of surface display systems are
numerous and include the development of bioadsorbents
and biocatalysts, the identification of new antibiotics and
antigens, and the delivery of vaccines and drugs. While
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tially exciting and challenging areas that have recently
attracted researchers' attention worldwide. Proteins able
to bind metal ions or other pollutants as well as enzymes
able to degrade polysaccharides when expressed in heter-
ologous hosts can be used as bioadsorbents for heavy
metal removal [4,5], as whole-cell biocatalysts for detoxi-
fication of harmful organic contaminants from the envi-
ronment [6], or for polysaccharide-degradation by the
food and paper pulp industry. Peptides expressed in
appropriate hosts are used to obtain combinatorial librar-
ies and then used for i) the determination of epitope spe-
cificity of monoclonal antibodies, ii) the identification of
interacting proteins and interaction sites [7] and iii) the
identification of new antibiotics [8-10]. Proteins and pep-
tides with high antigenic or pharmacological activity once
expressed in appropriate hosts have been used for the
development of new vaccines and drugs [11-13].
Several approaches have been undertaken to develop effi-
cient display systems expressing heterologous polypep-
tides on the surface of viruses [14], microbial [7,15],
mammalian [16] and insect [17] cells. All these systems
share a common theme, targeting recombinant proteins
to the cell surface by constructing gene fusions using
sequences from membrane-anchoring domains of surface
proteins [18]. Each surface display system involves at least
two components: a carrier protein, anchored on the cell
surface, and a heterologous passenger protein exposed
outside the cell. Several characteristics of carrier proteins
can affect the efficiency of surface display and have differ-
ent effects on the stability and integrity of the host cell. A
successful carrier protein should meet the following
requirements: i) it should have an efficient signal peptide
or transporting signal, to allow the fusion protein to go
through the inner membrane; ii) it should have a strong
anchoring motif, to avoid detachment from the surface;
and iii) it should be resistant to the proteases present in
the extracellular medium or in the periplasmic space.
The location of insertion, or fusion, of the heterologous
protein into the carrier protein is another important fac-
tor, since it can influence the stability, the activity and
post-translational modification of the fusion protein.
Therefore, fusions at the N-terminus, C-terminus or inte-
rior of the carrier protein (sandwich fusions) are, in some
cases, constructed with the same passenger to obtain an
efficient display. Some characteristics of the passenger
protein can also affect the translocation process and final
surface display. The folding structure of the passenger pro-
tein such as the formation of disulfide bridges at the peri-
plasmic side of the outer membrane [19] or the presence
of many charged or hydrophobic residues can affect trans-
location through the membrane [20]. The choice of the
host organism is also an essential step for efficient display.
A good host should be compatible with proteins to be dis-
played and should be easy to manipulate and cultivate
without cell lysis.
Bacterial Spore Coats
Spore coats are comprised of protein, have ordered arrays
of protomeric subunits, exhibit self-assembly and have
protective properties [3]. As dormant metabolically inac-
tive life forms, spores can survive indefinitely in a desic-
cated state, and indeed have been documented as
surviving intact for millions of years [21,22]. The spore
can resist temperatures as high as 90°C as well as exposure
to noxious chemicals [23]. Most (but not all) spore form-
ing bacteria belong to two principal genera, Bacillus and
Clostridium. Clostridia spore-formers, unlike Bacillus, only
differentiate under anaerobic conditions making Bacillus
the most amenable genus for study.
Bacillus species produce a single spore or endospore (as
opposed to fungal exospores), within the bacterial cell by
a process of differentiation requiring the coordinated
action of hundreds of developmental genes [24,25]. Typi-
cally mature spores are 0.8–1.2 µm in length and have
either a spherical or ellipsoidal shape (see Figure 1A). The
single bacterial chromosome is condensed within the cen-
tre of the spore known as the core. Layers of lipid mem-
brane and modified peptidoglycan surround the spore
core but the most important structure is the spore coat.
This laminated proteinaceous shell provides the spore
with resistance to organic solvents and lysozyme. In Bacil-
lus subtilis as many as 25 different coat proteins are present
in two distinct coat layers (Figure 1B), the inner and outer
coat, but in other species there is evidence that the coat is
less complex and may in some cases consist of only a few
protein types [3,26,27]. The structure and assembly of the
spore coat is now emerging as a model system to under-
stand complex morphogenetic assembly processes akin to
classical studies on phage T4 assembly. The outer, elec-
tron-dense, layer of the B. subtilis coat is comprised of 5
principal polypeptides, CotA (65 kDa), CotB (59 kDa),
CotG (24 kDa), CotC (11 kDa) and CotF (8 kDa). CotA is
a multi-copper oxidase [28,29] and can accumulate in
multimeric forms (observed microscopically) within the
sporulating cells in some coat-defective mutants [3]. Pre-
sumably oligomerisation and self-assembly of CotA pre-
cedes deposition onto the spore coat surface. The CotG
and CotB proteins have also been shown to interact cova-
lently [27] and in addition CotG [30] and also CotC
[31,32] have extremely unusual amino acid sequences
containing multiple repeats (>13) of 12–13 amino acids
rich in lysines and tyrosines. Furthermore, many of the
spore coat proteins have unusual profiles i.e. multimeric
forms and aberrant molecular masses, when examined by
SDS-PAGE. Recently, it has been shown that the spore
coat is actually flexible and can expand and contract andPage 2 of 10
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dehydrates and similarly for germination when the spore
rehydrates [33,34]. This aspect of a self-assembled struc-
ture is particulary interesting and might offer a number of
future applications in drug delivery, nanofabrication and
surface coatings.
Engineering the Bacterial Spore Coat
A strategy to engineer Bacillus subtilis spores to display het-
erologous antigens on the spore surface has been recently
reported [35] and is illustrated in Figure 2. A spore-based
display system provides several advantages with respect to
systems based on the use of bacterial cells, these include
the robustness of the bacterial spore allowing storage in
the desiccated form, ease of production, safety and a tech-
nological platform supported by extensive tools for
genetic manipulation.
In contrast to the wealth of information available on how
gene expression controls differentiation of a growing cell
into a dormant spore little is known about the mecha-
nisms of protein incorporation into the coat, the nature of
structural components forming the most external part of
the coat and whether there are anchoring motifs. Initial
attempts to expose heterologous proteins on the spore
surface have been focused on two coat components, CotB
and CotC. In the case of CotB this spore coat protein is
known to be surface located [35] while for CotC, relative
to other coat proteins, this species has a high relative
abundance [36]. The observation that both of these coat
components was dispensable for the formation of an
apparently normal spore as well as for its germination,
was an additional positive feature in choosing CotB and
CotC as potential carrier proteins.
Two antigens were initially selected as model proteins to
display on the spore surface: i) the non-toxic 459 amino
acid C-terminal fragment of the tetanus toxin (TTFC), a
well characterized and highly immunogenic 51.8 kDa
peptide [37], encoded by the tetC gene of Clostridium
tetani; and ii) the 103 amino acid B subunit of the heat-
labile toxin of enterotoxigenic strains of Escherichia coli
(LTB), a 12 kDa peptide, encoded by the eltB gene [38].
Bacterial endosporesFigure 1
Bacterial endospores. Panel A shows endospores from B. subtilis one of which is still retained within the rod shaped 'mother 
cell'. In B. subtilis, spores are approximately 1.2 µm in length and are ellipsoidal. Released spores have a clear protective shell 
known as the spore coat and is comprised of as many as 25 different protomeric components assembled into discrete layers. 
Panel B shows a typical SDS-PAGE (12.5%) fractionation of solubilised spore coat proteins revealing predominant species.Page 3 of 10
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Like other coat components, CotB has been associated to
the outer coat layer on the basis of genetic evidence [39]
and only recently an immunocytofluorimetric analysis
performed on intact spores has shown that CotB is acces-
sible to CotB-specific antibodies and therefore that it is
most probably exposed on the spore surface [35].
The CotB structural gene, cotB, is under the dual transcrip-
tional control of σK and the DNA-binding protein GerE.
As a consequence, cotB is transcribed only in the mother
cell compartment of the sporulating cell [27]. Once syn-
thesised in the mother cell cytoplasm, CotB is assembled
around the forming spore in a manner somehow depend-
ent on CotE, CotG and CotH. Therefore, CotB and the het-
erologous protein eventually fused to it, do not undergo a
cell wall translocation step, typical of display systems in
other bacteria.
Spore-surface display using spore coat proteinsFigure 2
Spore-surface display using spore coat proteins. The B. subtilis spore is composed of an internal core (yellow) sur-
rounded by a peptidoglycan-like cortex (in red) and a proteinaceous coat sub-divided into an inner (gree) and an outer (black) 
part. The fusion protein, composed by a carrier (blue) and a passenger (purple) part is exposed on the spore surface.Page 4 of 10
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by three 27 amino acid-repeats rich in serine, lysine and
glutamine residues. Serine residues account for over 50%
of the CotB C-terminal half. The lysine residues in the
CotB repeats have been suggested to represent sites of
intra- or inter-molecular cross-linking, by analogy to the
connective tissue proteins collagen and elastin [27,40].
The CotB protein has a deduced molecular mass of 46
kDa, but migrates on SDS-PAGE as a 59 kDa polypeptide.
Recently the discrepancy between measured and deduced
molecular weight has been explained by showing that
CotB is initially synthesized as a 46 kDa species, and con-
verted into a 59 kDa homodimer [41], that retains both
the N- an C-terminal ends predicted from the cotB nucle-
otide sequence.
The strategy to obtain recombinant B. subtilis spores
expressing CotB-TTFC or CotB-LTB on their surface was
based on (i) use of the cotB gene and its promoter for the
construction of translational fusions and (ii) chromo-
somal integration of the cotB-tetC and cotB-eltB gene
fusions into the coding sequence of the non-essential gene
amyE (Figure 3A) [42]. Placing the fusion proteins under
cotB transcriptional and translational signals ensured cor-
rect timing of expression during sporulation, while its
chromosomal integration guaranteed the genetic stability
of the construct. Due to the lack of information on CotB
coat assembly and on the requirements for anchoring
motifs, initial attempts were performed by positioning the
passenger protein at the C-terminal, the N-terminal or in
the middle of CotB (Fig. 3B).
When TTFC and LTB were fused to the C-terminal end of
CotB, the chimeric proteins failed to correctly assemble
on the spore surface (Isticato and Ricca, unpublished).
Such initial failures were attributed to a potential instabil-
ity of the constructs, either at the DNA level (repetitive
DNA sequences) or at the protein level. In order to bypass
such problems TTFC and LTB were fused to the C-terminal
end of a CotB form deleted of the three 27 amino acid-
repeats, CotB∆105-TTFC (Fig. 3A). In contrast to the full
length version, the CotB∆105-TTFC chimeric protein was
correctly assembled and exposed on the spore surface
[35]. A quantitative dot blot showed that each recom-
binant spore exposed an amount of CotB∆105-TTFC fusion
protein equal to 0.00022 pg making it possible to con-
clude that 1.5 × 103 chimeric molecules are present on the
surface of each recombinant spore [35].
Unlike CotB∆105-TTFC, CotB∆105-LTB was not properly
assembled. The strain expressing this chimera showed
reduced sporulation and germination efficiencies and its
spores were not resistant to lysozyme. These observations,
together with the SDS-PAGE analysis of the released coat
proteins, suggested that the presence of CotB∆105-LTB
strongly altered the spore coat layer. An in-silico analysis
showed some homology between the chimeric product
(in the fusion region) and LytF, a cell wall-associated
endopeptidase produced by B. subtilis during vegetative
growth, thus raising the possibility that the chimeric prod-
uct could interfere with proper coat formation by degrad-
ing some coat components (Mauriello and Ricca, data not
shown).
In addition to the C-terminal end fusion described above
the model passenger protein TTFC has been fused also at
the N-terminal and in the middle of CotB (Fig. 3B). In
both cases the CotB∆105 form of CotB was used to avoid
the problems experienced with the C-terminal fusion (see
above). Both the N-terminal and the sandwich fusions
originated chimeric products that were properly assem-
bled in the coat structure from both the qualitative and
the quantitative point of view [35]. At least in the case of
CotB, it was then possible to conclude that where the pas-
senger protein is exposed it does not affect display on the
spore surface.
CotC as a carrier protein
CotC is a 12 kDa, alkali-soluble component of the B. sub-
tilis spore coat, previously identified by reverse genetics
[32] and then associated to the outer coat layer based on
genetic evidence [39]. CotC was initially considered as a
carrier candidate because of its relative abundance in the
coat (Figure 1B). Together with CotG and CotD, CotC rep-
resents about 50% of the total solubilized coat proteins.
Such relatively high amounts could allow the assembly of
a significant number of CotC-based chimeras on the coat,
thus ensuring an efficient heterologous display. Expres-
sion of the cotC gene is under the control of the mother
cell specific σ-factor σK and of transcriptional regulators
GerE and SpoIIID. As in the case of CotB, CotC is also
transcribed in the mother cell and its assembly on the coat
does not require membrane translocation. The primary
product of the cotC gene is a 66 amino acid polypeptide
extremely rich in tyrosine (30.3%) and lysine (28.8%) res-
idues [32]. However, it was recently shown that CotC is
assembled into at least four distinct protein forms, rang-
ing in size between 12 and 30 kDa [31]. Two of these, hav-
ing molecular masses of 12 and 21 kDa and
corresponding most likely to a monomeric and
homodimeric form of CotC respectively, are assembled
on the forming spore right after their synthesis eight hours
after the onset of sporulation. The other two forms, 12.5
and 30 kDa, are probably the products of post-transla-
tional modifications of the two other forms, occurring
directly on the coat surface during spore maturation [31].
In the case of CotC only C-terminal fusions have been so
far constructed (Figure 3B). Both CotC-TTFC and CotC-
LTB gene fusions were obtained by cloning tetC or eltB inPage 5 of 10
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and translational control of the cotC promoter region. The
gene fusion was then integrated into the B. subtilis chro-
mosome at the amyE locus by double cross-over recombi-
nation [36] (Figure 3A). Both these two chimeric proteins
were assembled on the coat of recombinant spores with-
out major effect on the spore structure and/or function,
since they appeared identical to wild type spores in terms
of efficiency of sporulation and germination and
resistance properties. Western blot, cytofluorimetric anal-
ysis and, for CotC-TTFC, immunofluorescence
microscopy (Figure 4) showed that both CotC-based chi-
Spore-surface display system in B. subtilisFigure 3
Spore-surface display system in B. subtilis. (A) Schematic view of the integration of gene fusions on the chromosome. Red 
bars represent the gene fusion, grey and green bars represent respectively the non-essential amyE gene of B. subtilis used as 
integrational site and the chloramphenicol acetyl transferase (cat) gene used as a selectable marker. (B) Schematic representa-
tion of fusion proteins using either full length CotB (380 amino acids) or CotB∆105 (275 amino acids) or CotC (66 amino 
acids) as carrier proteins (all in blue). The three 27-amino-acids repeats of full lenght CotB and the part of them remaining in 
CotB∆105 are in black. Purple bars represent the heterologous part of the fusions (TTFC or LTB).Page 6 of 10
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spores. A quantitative determination of recombinant pro-
teins exposed on B. subtilis spores revealed that ca. 9.7 ×
102 and 2.7 × 103 molecules of CotC-TTFC and CotC-LTB,
respectively, were extracted from each spore.
Although CotC appears more abundant than CotB within
the coat, comparable amounts of heterologous proteins
are exposed by the CotC-based and the CotB∆105-based
systems. This result was somewhat unexpected, since
CotC appears to be much more abundant than CotB in
the coat. A possible explanation comes from the recent
Detection of presence of CotC-LTB and CotC-TTFC by immunofluorescence microscopyFigure 4
Detection of presence of CotC-LTB and CotC-TTFC by immunofluorescence microscopy. Sporulation of B. subti-
lis strains was induced by the resuspension method, and samples were taken 6 h after the onset of sporulation and analysed by 
immunofluorescence microscopy as described previously [46]. Samples were labelled with mouse anti-LTB antibody followed 
by anti-mouse IgG-TRITC conjugate (red fluorescein, Panels A & B), or rabbit anti-TTFC antibody followed by anti-rabbit IgG-
FITC conjugate (green fluorescein, Panels C & D). Panels A & C, wild type spores; Panel B, isogenic spores expressing CotC-
LTB); Panel D, isogenic spores expressing CotC-TTFC.Page 7 of 10
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tial for interaction with other CotC molecules but also to
other coat components (Isticato and Ricca, manuscript in
preparation) and therefore shows that the use of CotC as
a carrier still needs to be optimised.
Stability of Spore-Displayed Proteins
One of the main reasons to propose the use of the bacte-
rial spore as a favourable display system is its well-docu-
mented stability. Spores can be simply stored at room
temperature for a long time without reduction of their
resistance and stability properties. This would be an
extremely useful property for a variety of biotechnological
applications. As an example, if the passenger protein is an
antigen, the recombinant spore could become an ideal
heat-stable oral vaccine for use in developing countries,
where heat-stability is of most concern due to poor distri-
bution and storage.
However, while spore stability is well documented [23],
stability of heterologous proteins exposed on the spore
surface has only recently been investigated. Spores
expressing CotB∆105-TTFC (see above) and parental
spores were stored at -80°C, -20°C, +4°C and at room
temperature and assayed at different storage times up to
12 weeks. In all cases the amount of heterologous protein
present on the surface of recombinant spores appeared
identical between freshly prepared spores and those
stored for up to 12 weeks (Fig. 5). These results, indicating
that heterologous proteins can be stably exposed on the
surface of recombinant spores, confirm the spore-based
system as a very promising display approach that could
overcome some drawbacks of other systems and that
could find applications in a variety of diverse biotechno-
logical fields.
Dot blot analysis of proteins extracted from wild-type spores and from spores exposing the CotB∆105-TTFC chimeraFigure 5
Dot blot analysis of proteins extracted from wild-type spores and from spores exposing the CotB∆105-TTFC 
chimera. Freshly purified spores expressing the CotB∆105-TTFC chimera (t0) or after 4, 8 or 12 weeks (t4, t8 and t12) of 
storage at room temperature were examined by dot blotting of extracted spore coat proteins. Concentrations of purified 
TTFC (in nanograms) and of coat proteins (in micrograms) are indicated. Proteins were loaded and reacted with monoclonal 
anti-TTFC antibodies (Boeringher), then with phosphatase-conjugated secondary antibodies. Signals of similar intensity were 
obtained with freshly purified spores and spores stored at room temperature for up to 12 weeks.Page 8 of 10
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Model Disease
Spores expressing CotB∆105-TTFC have been used to
immunise mice by the oral route [43]. Serum IgG and fae-
cal sIgA showed clear seroconversion to TTFC. The dosing
schedule used three sets of three doses (1.67 × 1010) over
5 weeks and was based on regimes optimised for oral
immunisations [44,45]. The titres of TTFC-specific IgG
after 33 days (>103) suggested that these were at protective
levels and mice challenged with tetanus toxin correspond-
ing to 10 LD50 were fully protected. Out of eight mice chal-
lenged with a 20 LD50 dose seven survived suggesting that
this was the threshold for protection. A similar study was
made using nasal immunisation with CotB-TTFC spores
but with a lower dose and three immunisations [43].
Here, TTFC-specific IgG responses were lower but still
showed seroconversion. These studies show that engi-
neered spores expressing a heterologous antigen can be
used for protective immunisation. Moreover, although
mucosal responses are not important for protection
against Clostridium tetani (a systemic pathogen) they are
obviously important for mucosal pathogens. Further stud-
ies will be needed to optimise dosing regimes (less doses
and less spores) but these seminal studies have opened
the way for development against specific mucosal patho-
gens. Although these studies are encouraging and demon-
strate humoral responses there is no clear evidence yet
that indicates cellular responses. However, spores have
been shown to disseminate to the GALT and are found in
the Peyer's Patches (PP) and mesenteric lymph nodes
[46]. The small size of the spore (1 µm) would allow it to
be taken up by M cells and transported to the PP where it
could interact with antigen presenting cells. Initial studies
have shown that spores can germinate and persist for a
short period of time within intestinal macrophages as well
as elicit Th 1 cytokines in vivo such as IFN-γ [47].
Conclusions
The protective coat of the bacterial spore offers two areas
of interest for long-term exploitation pertinent to nanobi-
otechnology. First, as a substrate for delivery of biomole-
cules and second as a source for understanding self-
assembling molecules. As a delivery vehicle the spore coat
has been shown to provide a suitable surface for display
of heterologous antigens using the CotB and CotC pro-
teins. As vaccine vehicles spores have a number of advan-
tages over other second generation systems under
development. However, the same carried systems (CotB
and CotC) could also be used for delivery of proteins
important for industry (e.g. xylanases) or for drug deliv-
ery. It is probable that other spore coat proteins can be
used for surface expression and delivery and indeed spore-
forming species other than B. subtilis could be developed.
The spore coat carries scores of different protomers of
which some self-assemble although little is currently
known about how this occurs. Accordingly, the assembly
processes that form the spore coat as well as the nature of
individual proteins could provide a rich source of hitherto
unknown self-assembling molecules.
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